| Not Yet Recruiting | Psoriasis Comorbidities at Hospital Calderón Guardia NCT07448337 | Caja Costarricense de Seguro Social | — |
| Not Yet Recruiting | Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease NCT07448402 | Caja Costarricense de Seguro Social | — |
| Not Yet Recruiting | The Effects of Audio-Based Therapy on Anxiety in Psoriasis NCT07390487 | University of California, San Francisco | N/A |
| Not Yet Recruiting | Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Not Yet Recruiting | Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chines NCT07351448 | Shanghai Yueyang Integrated Medicine Hospital | — |
| Recruiting | Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis NCT07401992 | Hospital Universitario Dr. Jose E. Gonzalez | Phase 4 |
| Withdrawn | Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy NCT07255781 | University of California, San Diego | — |
| Recruiting | Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada NCT07370766 | Chronicle Academy | — |
| Active Not Recruiting | A Trial of Academic Detailing to Promote Prescribing of Biosimilars NCT07221890 | Brigham and Women's Hospital | N/A |
| Recruiting | Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis NCT07298265 | Charite University, Berlin, Germany | — |
| Recruiting | A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis i NCT07233291 | Ahmed Ibrahim | Phase 2 |
| Recruiting | Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study NCT07169019 | Alexandria University | EARLY_Phase 1 |
| Recruiting | SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495 | Leiden University Medical Center | — |
| Recruiting | Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis NCT06982352 | LAPIX Therapeutics Inc. | Phase 1 |
| Not Yet Recruiting | Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients NCT06863493 | SFA Therapeutics | Phase 2 / Phase 3 |
| Completed | A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) NCT07181343 | Hansoh BioMedical R&D Company | Phase 1 |
| Recruiting | A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Mode NCT06987292 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | — |
| Recruiting | Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast) NCT06905028 | Charite University, Berlin, Germany | N/A |
| Enrolling By Invitation | Sulodexide in Controlling the Recurrence of Psoriasis NCT06982196 | Xijing Hospital | Phase 3 |
| Recruiting | A Study to Assess Deucravacitinib Safety in Pregnancy NCT07017699 | Bristol-Myers Squibb | — |
| Recruiting | Effect of Semaglutide in Patients With Psoriasis and Obesity NCT06937060 | The University of Hong Kong | Phase 3 |
| Recruiting | Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Informatio NCT06790940 | Shanghai Yueyang Integrated Medicine Hospital | — |
| Active Not Recruiting | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis NCT06846541 | Alumis Inc | Phase 3 |
| Active Not Recruiting | Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls NCT06897722 | Zhala Vatankha Sain | — |
| Recruiting | A Phase 2 Study of HB0017 in Psoriasis Patients NCT06592274 | Huabo Biopharm Co., Ltd. | Phase 2 |
| Recruiting | Molecular Inflammation Board at the Center for Personalized Medicine NCT07132333 | University Hospital Tuebingen | — |
| Completed | Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment NCT06666114 | Novartis Pharmaceuticals | — |
| Unknown | Chronic Inflammatory Disease, Lifestyle and Risk of Disease NCT03456206 | University of Southern Denmark | — |